The role of intercellular adhesion molecule-1 in head and neck cancer

Experimental Oncology

Volumn 28, Issue 4, 2006, Pages 270-274

  Georgolios, A ^a   Batistatou, A ^a   Bonitsis, N ^a   Stagikas, D ^a   Manolopoulos, L ^b   Charalabopoulos, K ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Adhesion molecules; Head neck cancer; ICAM 1; Intercellular adhesion molecule 1; Oral cancer

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

CANCER DIAGNOSIS; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAD AND NECK CANCER; HUMAN; NASOPHARYNX CARCINOMA; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SHORT SURVEY; THYROID CANCER;

ANIMALS; HEAD AND NECK NEOPLASMS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1;

EID: 33846866537     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (44)

1. Charalabopoulos K, Binolis J, Karkabounas S. Adhesion molecules in carcinogenesis. Exp Oncol 2002; 24: 249-57.
2. Charalabopoulos K, Papalimneou V, Charalabopoulos A. Adhesion molecules in lung cancer. Exp Oncol 2003; 25: 16-21.
3. Charalabopoulos K, Gogali A, Kostoula OK, Constantopoulos SH. Cadherin superfamily of adhesion molecules in primary lung cancer. Exp Oncol 2004; 26: 256-60.
4. Gogali A, Charalabopoulos K, Constantopoulos S. Integrin receptors in primary lung cancer. Exp Oncol 2004; 26: 106-10.
5. Georgolios A, Batistatou A, Charalabopoulos A, Manolopoulos L, Charalabopoulos K. The role of CD44 adhesion molecule in oral cavity cancer. Exp Oncol 2006; 28: 94-8.
6. Dougherty DJ, Murdoch S, Hogg N. The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur J Immunol 1988; 18: 35-9.
7. Smith CW. Leukocyte-endothelial cell interactions. Semin Hematol 1993; 30: 45-53.
8. Singer KH. Interactions between epithelial cells and T lymphocytes: role of adhesion molecules. Adv Drug Deliv Rev 2004; 56: 763-78.
9. Piela TH, Korn JH. ICAM-1-dependent fibroblast-lymphocyte adhesion: discordance between surface expression and function of ICAM-1. Cell Immunol 1990; 129: 125-37.
10. Hopkins AM, Baird AW, Nusrat A. ICAM-1: targeted docking for exogenous as well as endogenous ligands. Adv Drug Deliv Rev 2004; 56: 763-78.
11. Huang C, Springer TA. A binding interface on the I domain of lymphocyte function-associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule 1 (ICAM-1). J Biol Chem 1995; 270: 19008-16.
12. Goebeler M, Gutwald J, Roth J, Meinardus-Hager G, Sorg C. Expression of intercellular adhesion molecule-1 in murine allergic contact dermatitis. Int Arch Allergy Appl Immunol 1990; 93: 294-9.
13. Griffiths CE, Nickoloff BJ. Keratinocyte intercellular adhesion molecule-1 (ICAM-1) expression precedes dermal T lymphocytic infiltration in allergic contact dermatitis (Rhus dermatitis). Am J Pathol 1989; 135: 1045-53.
14. Hodge JW, Sabzevari H, Yafal AG, Gritz L, Lorenz MG, Schlom J. A triad of costimulatory molecules synergize to amplify T-cell activation. Cancer Res 1999; 59: 5800-7.
15. Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, Ekblom J, Denissenko MF. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 2005; 26: 943-50.
16. Beksac M, Arat M, Akan H, Koc H, Ilhan O, Ozcan M. Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-alpha-2a treatment. Cancer 2000; 89: 1474-81.
17. Terol MJ, Tormo M, Martinez-Climent JA, Marugan I, Benet I, Ferrandez A, Teruel A, Ferrer R, Garcia-Conde J. Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome. Ann Oncol 2003; 14: 467-74.
18. Mizoi T, Ohtani H, Suzuki Y, Shiiba K, Matsuno S, Nagura H. Intercellular adhesion molecule-1 expression by macrophages in human gastrointestinal carcinoma: possible roles as host immune/inflammatory reaction. Pathol Int 1995; 45: 565-72.
19. Johnson JP. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev 1999; 18: 345-57.
20. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-93.
21. Banks RE, Gearing AJ, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 1993; 68: 122-4.
22. Dustin ML, Singer KH, Tuck DT, Springer TA. Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1). J Exp Med 1988; 167: 1323-40.
23. Kim SY, Chu KC, Lee HR, Lee KS, Carey TE. Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol 1997; 117: 775-84.
24. Yamanoto T, Yoneda K, Ueta E, Osaki T. Serum cytokines, interleukin- 2 receptor and soluble intercellular adhesion molecule-1 in oral disorders. Oral Surg Oral Med Oral Pathol 1994; 78: 727-35.
25. Liu CM, Sheen TS, Ko JY, Shun CT. Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM-1) in head and neck cancer. Br J Cancer 1999; 79: 360-2.
26. Akcay F, Taysi S, Uslu C, Dogru Y, Gumustekin K. Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with laryngeal cancer. Jpn J Clin Oncol 2001; 31: 584-8.
27. van der Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996; 74: 13-33.
28. Pizzolo G, Vinante F, Nadali G, Ricetti MM, Morosato L, Marrocchella R, Vincenzi C, Semenzato G, Chilosi M. ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's disease. Br J Haematol 1993; 84: 161-2.
29. Harabuchi Y, Kataura A, Imai K. Circulating intercellular adhesion molecule-1 and its cellular expression in head and neck non-Hodgkin's lymphomas, including lethal midline granuloma. Ann Otol Rhinol Laryngol 1996; 105: 634-42.
30. Terol MJ, Tormo M, Martinez-Climent JA, Marugan I, Benet I, Ferrandez A, Teruel A, Ferrer R, Garcia-Conde J. Soluble intercellular adhesion molecule-1 (s-ICAM-1/S-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome. Ann Oncol 2003; 14: 467-74.
31. Wolowiec D, Frydecka I, Kapelko-Slowik K, Potoczek S, Urbaniak-Kujda D, Kuliczkowski K. Blood serum levels of soluble forms of adhesion molecules ICAM-1 (sICAM-1) and selectin E (s-selectin E) in patients with various phases of non-Hodgkin's lymphomas. Med Sci Monit 2002; 8: 175-8.
32. Yu Y, Dong W, Zhou X, Li S. The significance of serum soluble intercellular adhesion molecule 1 and transforming growth factor alpha in patients with nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2004; 130: 1205-8.
33. Liu CM, Ko JJ, Shun CT, Hsiao TY, Sheen TS. Soluble adhesion molecules and cytokines in tumor-associated tissue eosinophilia of nasopharyngeal carcinoma. Acta Otolaryngol 2001; 121: 534-8.
34. Busson P, Zhang Q, Guillon JM, Gregory CD, Young LS, Clausse B, Lipinski M, Rickinson AB, Tursz T. Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein - Barr-virus-positive nasopharyngeal carcinoma cells. Int J Cancer 1992; 50: 863-7.
35. Farwell DG, McDougall JK, Coltrera MD. Expression of Epstein-Barr virus latent membrane proteins leads to changes in keratinocyte cell adhesion. Ann Otol Rhinol Laryngol 1999; 108: 851-9.
36. Ruco LP, Stoppacciaro A, Uccini S, Breviario F, Dejana E, Gallo A, De Vincentiis M, Pileri S, Nicholls JM, Baroni CD. Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in undifferentiated nasopharyngeal carcinoma (lymphoepithelioma) and in malignant epithelial tumors. Hum Pathol 1994; 25: 924-8.
37. Uccini S, Ruco LP, Monardo F, La Parola IL, Cerimele D, Baroni CD. Molecular mechanisms involved in intraepithelial lymphocyte migration: a comparative study in skin and tonsil. J Pathol 1993; 169: 413-9.
38. Pasieka Z, Kuzdak K, Czyz W, Stepien H, Komorowski J. Soluble intracellular adhesion molecules (sICAM-1, sVCAM-1) in peripheral blood of patients with thyroid cancer. Neoplasma 2004; 51: 34-7.
39. Pasieka Z, Stepien H, Komorowski J, Kolomecki K, Kuzdak K. Evaluation of the levels of bFGF, VEGF, sICAM-1, and sVCAM-1 in serum of patients with thyroid cancer. Recent Results Cancer Res 2003; 162: 189-94.
40. Nakashima M, Eguchi K, Ishikawa N, Yamashita I, Sakai M, Ida H, Kawabe Y, Ito K, Nagataki S. Expression of adhesion molecule ICAM-1 (CD54) in thyroid papillary adenocarcinoma. J Endocrinol Invest 1994; 17: 843-8.
41. Bassi V, De Riu S, Feliciello A, Altomonte M, Allevato G, Rossi G, Fenzi GF. Intercellular adhesion molecule-1 is upregulated via the protein kinase C pathway in human thyroid carcinoma cell lines. Thyroid 1998; 8: 23-8.
42. Shirai A, Furukawa M, Yoshizaki T. Expression of intercellular adhesion molecule (ICAM-1) in adenoid cystic carcinoma of the head and neck. Laryngoscope 2003; 113: 1955-60.
43. Xue F, Zhang Y, Liu F, Jing J, Ma M. Expression of IgSF in salivary adenoid cystic carcinoma and its relationship with invasion and metastasis. J Oral Pathol Med 2005; 34: 295-7.
44. Perschbacher K, Jackson-Boeters L, Daley T. The adhesion molecules NCAM, HCAM, PECAM-1 and ICAM-1 in normal salivary gland tissues and salivary gland malignancies. J Oral Pathol Med 2004; 33: 230-6.